Royalty Report: Medical, Diagnostic, Dental – Collection: 26204

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Diagnostic
  • Dental
  • Cancer
  • Device
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26204

License Grant
We completed a settlement Agreement that was the result of a mediated settlement.  This relates to the agreement with Licensor for ViziLite® products.
License Property
The ViziLite device is used in conjunction with a conventional visual oral mucosal examination to improve the identification, evaluation and monitoring of oral mucosal abnormalities in those at increased risk for oral cancer. The ViziLite test kit includes a hand-held disposable chemiluminescent light and a one-percent acetic mouth rinse that work together to help dental professionals detect abnormalities in the oral cavity that might not be visible to the unaided eye.

The settlement addresses changes to the contractual restrictions relating to sales milestones as well as royalty rates for net sales of the ViziLiteâ„¢ products.

Field of Use
ViziLite is a test that uses fluorescent light to help dentists spot abnormal changes in the mucous membranes that line the inside of the mouth and throat.  ViziLite exam can help your dentist or hygienist identify abnormal tissue, that might develop into oral cancer.' The key consideration, however, should be whether ViziLite-assisted screening is more effective than standard screening in which the dentist looks with the naked eye using ordinary (incandescent) light.

IPSCIO Record ID: 2489

License Grant
The Licensee announced the acquisition of the world marketing rights excluding the Pacific Rim for the ViziLite TM chemiluminescent light technology.
License Property
The ViziLite device is used in conjunction with a conventional visual oral mucosal examination to improve the identification, evaluation and monitoring of oral mucosal abnormalities in those at increased risk for oral cancer.

The ViziLite test kit includes a hand-held disposable chemiluminescent light and a one-percent acetic mouth rinse that work together to help dental professionals detect abnormalities in the oral cavity that might not be visible to the unaided eye.

Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 6066

License Grant
The Licensee exclusively licensed a portfolio of seven patents from the University for diagnostic products used in the dental field.
License Property
Optical Coherence Tomography (OCT) is generally regarded as the 6th Imaging Modality and is a new, light-based system with characteristics that make it ideally suited to bio-medical diagnostic imaging applications.  OCT represents a major advancement in imaging in dentistry due its ability to provide detailed characterization of the dental microstructures, enabling the dentist to make earlier and more accurate diagnosis of oral disease including decay and periodontal disease.  The early detection of tooth decay facilitates the dentist to employ non- or minimally invasive techniques to treat or even reverse decay and periodontal disease.  Less invasive treatment enhances the patient experience and results in a higher level of professional service and patient care. The proprietary OCT Dental Imaging System(TM) will be used by dentists to obtain a real-time chairside evaluation of the oral tissues to aid in the early detction of decay, periodontal disease and microstructural deficiencies.

In general, Optical Coherence Tomography, or ‘OCT’, is a technique for obtaining sub-surface images of translucent or opaque materials at a resolution equivalent to a low-power microscope. It is effectively ‘optical ultrasound’, imaging reflections from within tissue to provide cross-sectional images.

Patent No.
5,570,182; 6,179,611; 6,385,358; 6,419,484; 6,451,009; 6,466,713, 6,522,407

Field of Use
The rights granted apply to the dental field.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.